Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2018

Jan 8, 2018

31802_dirs_2018-01-08_97a74eab-2815-4b77-89bc-29f67b244c79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-12-29

Reporting Person: CARREL MICHAEL H (Director, President, CEO, & Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-29 Common Stock A 547 $15.50 Acquired 669843 Direct

Footnotes

F1: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2017.

F2: Closing price on December 29, 2017 was $18.24.